BioSenic S.A. (BIOS.BR)

EUR 0.01

(-5.71%)

Operating Expenses Summary of BioSenic S.A.

  • BioSenic S.A.'s latest annual operating expenses in 2023 was 7.58 Million EUR , up 227.14% from previous year.
  • BioSenic S.A.'s latest quarterly operating expenses in 2024 Q2 was 1.58 Million EUR , down 0.0% from previous quarter.
  • BioSenic S.A. reported a annual operating expenses of 2.31 Million EUR in annual operating expenses 2022, down -82.2% from previous year.
  • BioSenic S.A. reported a annual operating expenses of 13.02 Million EUR in annual operating expenses 2021, down -18.67% from previous year.
  • BioSenic S.A. reported a quarterly operating expenses of 1.58 Million EUR for 2024 Q1, down -4.73% from previous quarter.
  • BioSenic S.A. reported a quarterly operating expenses of 7.34 Million EUR for 2023 FY, up 217.0% from previous quarter.

Annual Operating Expenses Chart of BioSenic S.A. (2023 - 2012)

Historical Annual Operating Expenses of BioSenic S.A. (2023 - 2012)

Year Operating Expenses Operating Expenses Growth
2023 7.58 Million EUR 227.14%
2022 2.31 Million EUR -82.2%
2021 13.02 Million EUR -18.67%
2020 16.01 Million EUR 43.34%
2019 11.17 Million EUR -10.36%
2018 12.46 Million EUR 1.06%
2017 12.33 Million EUR -3.63%
2016 12.79 Million EUR 4.7%
2015 12.22 Million EUR 117.32%
2014 5.62 Million EUR 39.09%
2013 4.04 Million EUR 10.43%
2012 3.66 Million EUR 0.0%

Peer Operating Expenses Comparison of BioSenic S.A.

Name Operating Expenses Operating Expenses Difference
ABIONYX Pharma SA 4.17 Million EUR -81.542%
ABIVAX Société Anonyme 127.37 Million EUR 94.047%
Adocia SA 15.62 Million EUR 51.481%
Aelis Farma SA 18.81 Million EUR 59.706%
Biophytis S.A. 14.33 Million EUR 47.094%
Advicenne S.A. 8.21 Million EUR 7.693%
genOway Société anonyme 16.73 Million EUR 54.697%
IntegraGen SA 5.35 Million EUR -41.672%
Medesis Pharma S.A. 1.56 Million EUR -384.669%
Neovacs S.A. 10.34 Million EUR 26.689%
NFL Biosciences SA 4.37 Million EUR -73.351%
Plant Advanced Technologies SA 2.76 Million EUR -174.264%
Quantum Genomics Société Anonyme 1.71 Million EUR -341.394%
Sensorion SA 27.05 Million EUR 71.971%
Theranexus Société Anonyme 3 Million EUR -152.347%
TME Pharma N.V. 5.49 Million EUR -37.948%
Valbiotis SA 9.86 Million EUR 23.163%
TheraVet SA 1.64 Million EUR -361.165%
Valerio Therapeutics Société anonyme 20.32 Million EUR 62.682%
argenx SE 1.34 Billion EUR 99.435%
Celyad Oncology SA 8.49 Million EUR 10.683%
DBV Technologies S.A. 89.4 Million EUR 91.518%
Galapagos NV 327.98 Million EUR 97.688%
Genfit S.A. 54.8 Million EUR 86.163%
GeNeuro SA 14.35 Million EUR 47.184%
Hyloris Pharmaceuticals SA 17.98 Million EUR 57.842%
Innate Pharma S.A. 64.57 Million EUR 88.256%
Inventiva S.A. 120.18 Million EUR 93.691%
MaaT Pharma SA 21.59 Million EUR 64.89%
MedinCell S.A. 32.92 Million EUR 76.967%
Nanobiotix S.A. 58.92 Million EUR 87.132%
Onward Medical N.V. 20.64 Million EUR 63.27%
Oryzon Genomics S.A. 18.49 Million EUR 59.004%
OSE Immunotherapeutics SA 23.58 Million EUR 67.854%
Oxurion NV 12.21 Million EUR 37.916%
Pharming Group N.V. 204.24 Million EUR 96.287%
Poxel S.A. 28.76 Million EUR 73.638%
GenSight Biologics S.A. 32.66 Million EUR 76.782%
Transgene SA 31.23 Million EUR 75.72%
Financière de Tubize SA 114.38 Thousand EUR -6529.134%
UCB SA 2.94 Billion EUR 99.742%
Valneva SE 134.92 Million EUR 94.38%
Vivoryon Therapeutics N.V. 24.69 Million EUR 69.29%